CancerWorld

For parents of children battling cancer, finding a place to stay that is both affordable and close to the hospital is not just a convenience; it can mean the difference between life and death. Without accommodation, families are often forced…

It was an interview during which I simply couldn’t stop smiling, amazed by the brilliance of Prof. Paul Mischel, yet he speaks about his discoveries with such ease, clarity, and enthusiasm that you can’t help but be carried along. Here…

Could artificial sweeteners undo the benefits of immunotherapy? A study published in Cancer Discovery, July 30, found that melanoma and non-small cell lung cancer (NSCLC) patients who consume high levels of the artificial sweetener sucralose have worse responses to immunotherapy…

From Rome to Milan to ESMO’s presidency — a story of science, courage, and mentorship. I am in Yerevan. Giuseppe Curigliano is in Milan, just back from Asia. “JSMO, CSCO, Korea, Japan, China…” he sighs, then laughs. “Too much travel?”…

CancerWorld is a platform for telling human stories that unfold across science, politics, and society, going beyond the investigation of cancer biology and therapy. In our October 2025 issue, we open with one of two cover stories: the profile of…

Given the global estimate that approximately 9 to 14 million metric tons of plastic enter the oceans yearly—continuing to fragment into microplastics (MPs)—the urgency to understand their potential health effects has escalated. Particularly concerning is the growing body of evidence…

Latvia consistently ranks among the European Union's most troubled countries when it comes to cancer. The country lags behind EU countries on many cancer risk factors and also has one of the biggest gender disparities on the continent, with men…

Women who survive breast cancer may face a surprising advantage: a lower risk of developing Alzheimer’s disease than their peers without cancer. The cohort study, published in JAMA Network Open, 20 June, found that breast cancer survivors had an 8%…

For decades, early cancer detection has predominantly relied on organ-specific screening programs—such as mammography, Pap test, or colonoscopy—to detect malignancies as early as possible. While these approaches have indisputably saved lives, they inherently capture only a limited range of cancers,…